These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


386 related items for PubMed ID: 2629828

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Behavior of plasma and urine purines, after a purine-free diet, in normal subjects and patients with gout].
    Vannoni D, Porcelli B, Di Stefano A, Pizzichini M, Leoncini R, Terzuoli L, Taddeo A, Marsini S, Morozzi G, Marcolongo R.
    Medicina (Firenze); 1989; 9(3):295-7. PubMed ID: 2615605
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [The level of oxypurines in the plasma and urine of control and gout patients. (Correlation with the level of uric acid)].
    Auscher C, Brouilhet H, Delbarre F.
    Sem Hop; 1967 Apr 08; 43(17):1123-6. PubMed ID: 4293530
    [No Abstract] [Full Text] [Related]

  • 8. Renal handling of hypoxanthine and xanthine in normal subjects and in cases of idiopathic renal hypouricemia.
    Kaneko K, Fujimori S, Kanbayashi T, Akaoka I.
    Adv Exp Med Biol; 1989 Apr 08; 253A():309-15. PubMed ID: 2624208
    [No Abstract] [Full Text] [Related]

  • 9. Plasma concentrations and urinary excretion of purine bases (uric acid, hypoxanthine, and xanthine) and oxypurinol after rigorous exercise.
    Kaya M, Moriwaki Y, Ka T, Inokuchi T, Yamamoto A, Takahashi S, Tsutsumi Z, Tsuzita J, Oku Y, Yamamoto T.
    Metabolism; 2006 Jan 08; 55(1):103-7. PubMed ID: 16324927
    [Abstract] [Full Text] [Related]

  • 10. Hypoxanthine and xanthine transport through the blood-brain barrier in hypoxanthine phosphoribosyltransferase (HPRT) deficiency.
    Jiménez ML, Puig JG, Mateos FA, Ramos TH, Castroviejo IP, Vázquez JO.
    Adv Exp Med Biol; 1989 Jan 08; 253A():173-9. PubMed ID: 2624187
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. An enzymatic basis for variation in response to allopurinol. Hypoxanthine-guanine phosphoribosyltransferase deficiency.
    Kelley WN, Rosenbloom FM, Miller J, Seegmiller JE.
    N Engl J Med; 1968 Feb 08; 278(6):287-93. PubMed ID: 5638346
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Purine metabolism in human tumors].
    Vannoni D, Porcelli B, Caldarone R, Garzi A.
    Medicina (Firenze); 1989 Feb 08; 9(1):51-4. PubMed ID: 2739532
    [Abstract] [Full Text] [Related]

  • 16. Theophylline-induced increase in plasma uric acid--purine catabolism increased by theophylline.
    Yamamoto T, Moriwaki Y, Suda M, Takahashi S, Hiroishi K, Higashino K.
    Int J Clin Pharmacol Ther Toxicol; 1991 Jul 08; 29(7):257-61. PubMed ID: 1889911
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [A study on treatment of hyperuricemia--effects and kinetics of allopurinol and oxipurinol].
    Hosoya T, Ichida K, Tabe A, Sakai O.
    Ryumachi; 1991 Feb 08; 31(1):28-35. PubMed ID: 1857993
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Hereditary nephropathy associated with hyperuricemia and gout.
    Puig JG, Miranda ME, Mateos FA, Picazo ML, Jiménez ML, Calvin TS, Gil AA.
    Arch Intern Med; 1993 Feb 08; 153(3):357-65. PubMed ID: 8427538
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 20.